http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106397455-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22
filingDate 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106397455-B
titleOfInvention A kind of anti-infectives Ceftibuten crystalline compounds and combinations thereof
abstract The invention belongs to pharmaceutical technology field, a kind of anti-infectives Ceftibuten crystalline compounds and combinations thereof are disclosed.Shown in the structural formula such as formula (I) of the Ceftibuten crystalline compounds, which is measured with powder x-ray diffraction measuring method, as shown in Figure 1 with the X-ray powder diffraction pattern that the 2 θ ± 0.2 ° angles of diffraction indicate.The crystalline compounds purity is high, and polymer content is low, and stability is good, and not easy to moisture absorption, good fluidity, substantially increases its dissolubility.Low using capsule dissolubility height, impurity content made of the crystalline compounds, stability is good.
priorityDate 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452784762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421272287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448186497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20981746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22605900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691

Total number of triples: 32.